SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Merck Launches Phase 3 Trial of Ohtuvayre for COPD Prevention

Merck has launched a Phase 3 trial evaluating Ohtuvayre for preventing COPD exacerbations.

MRK

Related stories